ABENA OFORI ATTA: Open Payments
NPI 1811534274 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 18 payments from 5 companies in 2025. Trend: 2023 $406 · 2024 $420 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $265 |
| Neurocrine BioSciences, Inc. | 6 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: COBENFY, INGREZZA, CAPLYTA, INVEGA SUSTENNA, REXULTI.
Industry payments across MD — which companies pay providers there.
